Interestingly, our results indicated that exogenous EGF alleviated the fibrotic phenotype only in keloid dermal fibroblasts, evident by a significantly decreased gene expression of FSP-1, α-SMA and vimentin, as well as decreased vimentin protein expression (Figure 5). This evidence concerns the gene S100A4 and keloid.